Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

EUROFINS INDIA

EUROFINS INDIA is listed as a small business research supplier in the Scientist.com network, with 3 sites in 1 country and 4 service areas.

View EUROFINS INDIA on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 3
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Agricultural Sciences Compliance and Quality Control Measures

  • OECD 106: Adsorption Study Estimate the adsorption/desorption behavior of a chemical on different soil types.

Antibodies

  • Antibody Purification Purify multiple antibody types including IgG, IgM, IgA and IgY.

Biomarkers

  • Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.

Chemical and Compound Analysis

  • Excipient Compatibility Test excipients for drug formulation, effects of temperature, time, humidity, pH and light exposure as well as excipient release.
  • GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • NMR Methods Use nuclear magnetic resonance spectroscopy to identify drug intermediates.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
Show all 10 in Chemical and Compound Analysis 4 more
  • Partition Coefficient Determine lipophilicity (hydrophobicity) of compounds by measuring log P.
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.

Chemistry, Manufacturing and Controls (CMC)

  • API manufacturing process development, tech transfer and validation API manufacturing process development, tech transfer and validation
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Drug Formulation Combine substances including the active drug into a final product with the desired metabolic and therapeutic properties.
  • GMP Synthesis Synthesize APIs including small molecules, formulations and protein-based drugs under GMP compliance.
  • Polymorph Screening Screen for unwanted API forms resulting from the drug formulation process.
  • Salt Form Selection Use high-throughput automated arrays to combine APIs with multiple salts and ions to optimize formulation.
Show all 130 services 115 more

Clinical Trials

  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.

Discovery Chemistry

  • Chiral Synthesis Synthesize a compound by a method that favors formation of a specific enantiomer or diastereomer.
  • Compound Management Buy, maintain and process compound libraries, natural product libraries and building blocks.
  • Compound Synthesis Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Compound Synthesis Services (IP-sensitive) Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Custom Building Blocks Find or synthesize mg to kg amounts of chemical building blocks, scaffolds and reactive intermediates.
  • Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
Show all 12 in Discovery Chemistry 6 more
  • HTS Libraries Find targeted and broad collections of chemical compounds for high throughput screening and ADMET applications.
  • Impurity Synthesis Use high resolution MS or NMR to eliminate intermediates or organic byproducts and determine impurity content.
  • Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.
  • Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
  • Stable Isotope Synthesis Label drug candidates with stable isotopes that simplify compound tracking and distribution studies.
  • Transporters Selectively screen for compounds with good permeability in the intestine, skin, or blood-brain barrier using drug transporter a...

Disease Models

  • Acute Kidney Failure Models Measure therapeutic endpoints in animal models of acute kidney failure.
  • Acute Liver Failure Models Measure therapeutic endpoints in animal models of acute liver failure.
  • Acute Lung Injury Models Measure therapeutic endpoints in animal models of acute lung injury.
  • Artery On-A-Chip Platform Assess small blood vessels under near-in vivo conditions.
  • Blood Models Test for therapeutic efficacy of drug candidates in blood disorder models.
  • Bone Models Measure therapeutic endpoints in animal models of bone disorders.
Show all 31 in Disease Models 25 more
  • Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
  • Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
  • Cartilage Repair Models Measure therapeutic endpoints in animal models of cartilage repair.
  • Comparative Pharmacology Compare drug responses across species for improved reliability in translational studies.
  • Critical Care Models Diagnose and manage life-threatening conditions requiring sophisticated organ support and invasive monitoring.
  • Emesis Models Measure therapeutic endpoints in animal models of emesis.
  • Hematopoiesis Models Measure therapeutic endpoints in animal models of hematopoiesis.
  • In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
  • Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
  • Microdialysis Models Measure the effect of drug candidates on neurotransmission in rat or mouse models.
  • Microsurgery in Rodents Outsource microsurgeries projects required for testing new therapies on a rodent model.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Osteoarthritis Models Measure therapeutic endpoints in animal models of osteoarthritis.
  • Osteoporosis Models Measure therapeutic endpoints in animal models of osteoporosis.
  • Receptor Binding Models Measure the binding and distribution of drugs and biologics in animal tissues.
  • Receptor Occupancy Models Determine the effective dose and concentration needed to reach effective levels in a given tissue.
  • SHR/NCrl Rat Use a single animal species to create one or more disease models fior hematopoesis.
  • Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.
  • Tissue Rejection Models Measure therapeutic endpoints in animal models of tissue rejection.
  • Ventricular Tachycardia Models Measure therapeutic endpoints in animal models of ventricular tachycardia.

General in vivo Toxicology

  • Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
  • Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
Show all 37 in In Vitro ADME 31 more
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Equilibrium Dialysis Measure the extent of binding of drugs to plasma proteins.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • Human Blood Brain Barrier on a Chip (BBBoC) Create a blood–brain barrier multicellular model to test drug delivery to the brain.
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Isotopic Labeling Track labeled isotopes through a metabolic pathway or cell by measuring mass, vibrational mode or radioactive decay.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.
  • Multidrug Resistance Identify potential causes of drug-drug interactions.
  • Nasal Permeability Test for passive diffusion and active transport in nasal permeability models.
  • No Label Methods Use mass spectrometry to detect and identify non-radiolabeled drug intermediates in pre-clinical samples.
  • Non Isotopic Labeling Track unlabeled macromolecules through a metabolic pathway or cell.
  • Ocular Permeability Measure passive diffusion and active transport of drugs across confluent ocular epithelial cells.
  • PharmacoScan - A Pharmacogenomics Tool Understand how genetic variation affects drug absorption, distribution, metabolism, and excretion (ADME) in a microarray plate.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Radiolabeled Tracers Use radiolabeled drug metabolites as radiotracers for measuring desired physiological processes.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.
  • Reference Standards Find reference standards for assays, tests and services.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.

In Vitro Assays

  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.

In Vitro Pharmacology

  • In Vitro Bone Models Measure osteoclast activity and bone formation in human or rat osteoclasts.
  • In Vitro Cardiovascular Models Measure stimulation and inhibition of lipolysis, adipogenesis and endothelial cell migration.
  • In Vitro Hypoxia Models Use in vitro models to measure therapeutic endpoints associated with hypoxia.
  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.

In Vitro Toxicology

  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.

In Vivo ADME

  • In Vivo Radiolabeled Metabolism Determine the qualitative and quantitative metabolism and/or degradation of an active ingredient in animals.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
Show all 9 in In Vivo Pharmacokinetics 3 more
  • Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Management Optimization & Development Strategies

  • OECD Regulatory Development Consultation in safety testing, chemical notification and registry within OECD.

Model Development

  • Japanese White Rabbit Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.
  • Zucker Rat Use a single animal species to create one or more disease models for cachexia.

Protein Sciences

  • Protein Binding Determine drug-protein binding interactions

Safety Pharmacology

  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
  • Telemetry Use implantable or external devices to study physiological parameters in model organisms

Testing Services

  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.

Other services

  • Implantable Telemetry for Large Animals Use implantable telemetry to study physiological parameters in large animals, such as dogs, primates, swine, sheep, horses, and cattle among others.
  • In Vivo Hollow Fiber Assay Evaluate test items concurrently with three different tumor cell lines within the same mouse.
  • New Request  

Service areas:

Biology Chemistry DMPK Pharmacology Toxicity

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • India Bengaluru, Bidadi 3 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Advinus Therapeutics provides integrated services as well as medicinal chemistry, DMPK, discovery biology, in vivo pharmacology, custom synthesis, bioanalytical and safety assessment services.

Website
www.advinus.com

Source: Scientist.com supplier network, written by the supplier

Get the EUROFINS INDIA report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with EUROFINS INDIA on Scientist.com

For prices, more details, or to contact EUROFINS INDIA, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.